{
  "id": [
    "26377365"
  ],
  "source": [
    "MED"
  ],
  "pmid": [
    "26377365"
  ],
  "pmcid": [
    "PMC5123709"
  ],
  "doi": [
    "10.1002/cam4.541"
  ],
  "title": [
    "Protein phosphatase methylesterase-1 (PME-1) expression predicts a favorable clinical outcome in colorectal cancer."
  ],
  "authorString": [
    "Kaur A, Elzagheid A, Birkman EM, Avoranta T, Kytölä V, Korkeila E, Syrjänen K, Westermarck J, Sundström J."
  ],
  "authorList": [
    {
      "author": [
        {
          "fullName": [
            "Kaur A"
          ],
          "firstName": [
            "Amanpreet"
          ],
          "lastName": [
            "Kaur"
          ],
          "initials": [
            "A"
          ],
          "authorId": [
            {
              "_": "0000-0003-2824-5272",
              "$": {
                "type": "ORCID"
              }
            }
          ],
          "affiliation": [
            "TuBS and TuDMM Doctoral Programmes, Turku, 20520, Finland."
          ]
        },
        {
          "fullName": [
            "Elzagheid A"
          ],
          "firstName": [
            "Adam"
          ],
          "lastName": [
            "Elzagheid"
          ],
          "initials": [
            "A"
          ],
          "affiliation": [
            "Biotechnology Research Center, Tripoli, Libya."
          ]
        },
        {
          "fullName": [
            "Birkman EM"
          ],
          "firstName": [
            "Eva-Maria"
          ],
          "lastName": [
            "Birkman"
          ],
          "initials": [
            "EM"
          ],
          "affiliation": [
            "Department of Pathology, University of Turku, Turku, 20520, Finland."
          ]
        },
        {
          "fullName": [
            "Avoranta T"
          ],
          "firstName": [
            "Tuulia"
          ],
          "lastName": [
            "Avoranta"
          ],
          "initials": [
            "T"
          ],
          "affiliation": [
            "Department of Social Services and Healthcare, City of Helsinki, Helsinki, 00099, Finland."
          ]
        },
        {
          "fullName": [
            "Kytölä V"
          ],
          "firstName": [
            "Ville"
          ],
          "lastName": [
            "Kytölä"
          ],
          "initials": [
            "V"
          ],
          "affiliation": [
            "BioMediTech, University of Tampere, Tampere, 33520, Finland."
          ]
        },
        {
          "fullName": [
            "Korkeila E"
          ],
          "firstName": [
            "Eija"
          ],
          "lastName": [
            "Korkeila"
          ],
          "initials": [
            "E"
          ],
          "affiliation": [
            "Department of Oncology and Radiotherapy, University of Turku and Turku University Hospital, Turku, 20521, Finland."
          ]
        },
        {
          "fullName": [
            "Syrjänen K"
          ],
          "firstName": [
            "Kari"
          ],
          "lastName": [
            "Syrjänen"
          ],
          "initials": [
            "K"
          ],
          "affiliation": [
            "Molecular Oncology Research Center, Barretos Cancer Hospital, Barretos, 14784-400, Brazil."
          ]
        },
        {
          "fullName": [
            "Westermarck J"
          ],
          "firstName": [
            "Jukka"
          ],
          "lastName": [
            "Westermarck"
          ],
          "initials": [
            "J"
          ],
          "affiliation": [
            "Turku Centre for Biotechnology, University of Turku and Åbo Akademi University, Turku, 20520, Finland."
          ]
        },
        {
          "fullName": [
            "Sundström J"
          ],
          "firstName": [
            "Jari"
          ],
          "lastName": [
            "Sundström"
          ],
          "initials": [
            "J"
          ],
          "affiliation": [
            "Department of Pathology, University of Turku, Turku, 20520, Finland."
          ]
        }
      ]
    }
  ],
  "authorIdList": [
    {
      "authorId": [
        {
          "_": "0000-0003-2824-5272",
          "$": {
            "type": "ORCID"
          }
        }
      ]
    }
  ],
  "journalInfo": [
    {
      "issue": [
        "12"
      ],
      "volume": [
        "4"
      ],
      "journalIssueId": [
        "2363752"
      ],
      "dateOfPublication": [
        "2015 Dec"
      ],
      "monthOfPublication": [
        "12"
      ],
      "yearOfPublication": [
        "2015"
      ],
      "printPublicationDate": [
        "2015-12-01"
      ],
      "journal": [
        {
          "title": [
            "Cancer medicine"
          ],
          "ISOAbbreviation": [
            "Cancer Med"
          ],
          "medlineAbbreviation": [
            "Cancer Med"
          ],
          "NLMid": [
            "101595310"
          ],
          "ESSN": [
            "2045-7634"
          ]
        }
      ]
    }
  ],
  "pubYear": [
    "2015"
  ],
  "pageInfo": [
    "1798-1808"
  ],
  "abstractText": [
    "Colorectal cancer (CRC) accounts for high mortality. So far, there is lack of markers capable of predicting which patients are at risk of aggressive course of the disease. Protein phosphatase-2A (PP2A) inhibitor proteins have recently gained interest as markers of more aggressive disease in certain cancers. Here, we report the role of PP2A inhibitor PME-1 in CRC. PME-1 expression was assessed from a rectal cancer patient cohort by immunohistochemistry, and correlations were performed for various clinicopathological variables and patient survival. Rectal cancer patients with higher cytoplasmic PME-1 protein expression (above median) had less recurrences (P = 0.003, n = 195) and better disease-free survival (DFS) than the patients with low cytoplasmic PME-1 protein expression (below median). Analysis of PPME-1 mRNA expression from TCGA dataset of colon and rectal adenocarcinoma (COADREAD) patient cohort confirmed high PPME1 expression as an independent protective factor predicting favorable overall survival (OS) (P = 0.005, n = 396) compared to patients with low PPME1 expression. CRC cell lines were used to study the effect of PME-1 knockdown by siRNA on cell survival. Contrary to other cancer types, PME-1 inhibition in CRC cell lines did not reduce the viability of cells or the expression of active phosphorylated AKT and ERK proteins. In conclusion, PME-1 expression predicts for a favorable outcome of CRC patients. The unexpected role of PME-1 in CRC in contrast with the oncogenic role of PP2A inhibitor proteins in other malignancies warrants further studies of cancer-specific function for each of these proteins."
  ],
  "affiliation": [
    "TuBS and TuDMM Doctoral Programmes, Turku, 20520, Finland."
  ],
  "language": [
    "eng"
  ],
  "pubModel": [
    "Print-Electronic"
  ],
  "pubTypeList": [
    {
      "pubType": [
        "Journal Article",
        "Research Support, Non-U.S. Gov't"
      ]
    }
  ],
  "meshHeadingList": [
    {
      "meshHeading": [
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Humans"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Colorectal Neoplasms"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "GE"
                  ],
                  "qualifierName": [
                    "genetics"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "MO"
                  ],
                  "qualifierName": [
                    "mortality"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "PA"
                  ],
                  "qualifierName": [
                    "pathology"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                },
                {
                  "abbreviation": [
                    "TH"
                  ],
                  "qualifierName": [
                    "therapy"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Carboxylic Ester Hydrolases"
          ],
          "meshQualifierList": [
            {
              "meshQualifier": [
                {
                  "abbreviation": [
                    "GE"
                  ],
                  "qualifierName": [
                    "genetics"
                  ],
                  "majorTopic_YN": [
                    "Y"
                  ]
                },
                {
                  "abbreviation": [
                    "ME"
                  ],
                  "qualifierName": [
                    "metabolism"
                  ],
                  "majorTopic_YN": [
                    "N"
                  ]
                }
              ]
            }
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Neoplasm Staging"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Prognosis"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Immunohistochemistry"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Proportional Hazards Models"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Signal Transduction"
          ]
        },
        {
          "majorTopic_YN": [
            "Y"
          ],
          "descriptorName": [
            "Gene Expression"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Adult"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Aged"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Middle Aged"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Female"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Male"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Kaplan-Meier Estimate"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Neoplasm Grading"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Patient Outcome Assessment"
          ]
        },
        {
          "majorTopic_YN": [
            "N"
          ],
          "descriptorName": [
            "Biomarkers, Tumor"
          ]
        }
      ]
    }
  ],
  "keywordList": [
    {
      "keyword": [
        "Survival",
        "Biomarker",
        "Colorectal Cancer",
        "Pp2a",
        "Tcga",
        "Pme-1"
      ]
    }
  ],
  "chemicalList": [
    {
      "chemical": [
        {
          "name": [
            "protein phosphatase methylesterase-1"
          ],
          "registryNumber": [
            "EC 3.1.1.-"
          ]
        },
        {
          "name": [
            "Carboxylic Ester Hydrolases"
          ],
          "registryNumber": [
            "EC 3.1.1.-"
          ]
        },
        {
          "name": [
            "Biomarkers, Tumor"
          ],
          "registryNumber": [
            "0"
          ]
        }
      ]
    }
  ],
  "subsetList": [
    {
      "subset": [
        {
          "code": [
            "IM"
          ],
          "name": [
            "Index Medicus"
          ]
        }
      ]
    }
  ],
  "fullTextUrlList": [
    {
      "fullTextUrl": [
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "pdf"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC5123709?pdf=render"
          ]
        },
        {
          "availability": [
            "Open access"
          ],
          "availabilityCode": [
            "OA"
          ],
          "documentStyle": [
            "html"
          ],
          "site": [
            "Europe_PMC"
          ],
          "url": [
            "http://europepmc.org/articles/PMC5123709"
          ]
        },
        {
          "availability": [
            "Subscription required"
          ],
          "availabilityCode": [
            "S"
          ],
          "documentStyle": [
            "doi"
          ],
          "site": [
            "DOI"
          ],
          "url": [
            "http://dx.doi.org/10.1002/cam4.541"
          ]
        }
      ]
    }
  ],
  "isOpenAccess": [
    "Y"
  ],
  "inEPMC": [
    "Y"
  ],
  "inPMC": [
    "N"
  ],
  "hasPDF": [
    "Y"
  ],
  "hasBook": [
    "N"
  ],
  "hasSuppl": [
    "N"
  ],
  "citedByCount": [
    "1"
  ],
  "hasReferences": [
    "Y"
  ],
  "hasTextMinedTerms": [
    "Y"
  ],
  "hasDbCrossReferences": [
    "N"
  ],
  "hasLabsLinks": [
    "N"
  ],
  "license": [
    "cc by"
  ],
  "epmcAuthMan": [
    "N"
  ],
  "hasTMAccessionNumbers": [
    "N"
  ],
  "dateOfCompletion": [
    "2016-10-13"
  ],
  "dateOfCreation": [
    "2016-01-15"
  ],
  "dateOfRevision": [
    "2016-12-30"
  ],
  "electronicPublicationDate": [
    "2015-09-17"
  ],
  "firstPublicationDate": [
    "2015-09-17"
  ]
}